Top health care startups
27,738
Startups
100
Rows shown
164,659
All startups
4 September 2026
Data as of
100 rows
| # | Company | City | Stage | Last round | Date | Total raised |
|---|---|---|---|---|---|---|
| 1 | Kelonia Therapeutics | Boston | Series A | Series A | 2022-04-28 | $50.0M |
| 2 | Craif | Tokyo | Series D+ | Series D | 2026-08-18 | $68.7M |
| 3 | Insilico Medicine | Cambridge | Series D+ | Series E | 2025-03-13 | $624.3M |
| 4 | Spring Health | New York | Series D+ | Series E | 2024-07-31 | $466.5M |
| 5 | OpenEvidence | Cambridge | Series D+ | Series D | 2026-01-21 | $767.0M |
| 6 | Inspiren | Brooklyn | Series B | Series B | 2025-09-25 | |
| 7 | Chai Discovery | San Francisco | Series C | Series C | 2026-07-14 | $631.0M |
| 8 | Assort Health | San Francisco | Series C | Series C | 2026-06-24 | $221.5M |
| 9 | LifeMine Therapeutics | Watertown | Series D+ | Series E | 2026-08-06 | $563.0M |
| 10 | Aureka Biotechnologies | Laguna Hills | Series B | Series B | 2026-08-10 | $168.4M |
| 11 | Fresha | London | Series C | Series C | 2026-05-21 | $299.0M |
| 12 | Pelage Pharmaceuticals | Los Angeles | Series B | Series B | 2025-10-15 | |
| 13 | Neko Health | Stockholm | Series C | Series C | 2026-07-15 | $1.0B |
| 14 | Colossal Biosciences | Austin | Series C | Series C | 2026-02-03 | $628.1M |
| 15 | Slate Medicines | Raleigh | Series A | Series A | 2026-02-24 | $130.0M |
| 16 | Expedition Therapeutics | San Francisco | Series B | Series B | 2026-08-05 | $280.0M |
| 17 | Infinimmune | Alameda | Series A | Series A | 2026-08-11 | $87.0M |
| 18 | Arintra | Austin | Series B | Series B | 2026-08-21 | $46.4M |
| 19 | InduPro | Seattle | Series B | Series B | 2026-08-12 | $162.0M |
| 20 | WellTheory | Atherton | Series A | Series A | 2025-10-14 | |
| 21 | Bridge to Life | Northbrook | Series C | Series C | 2026-08-12 | $167.5M |
| 22 | Midi Health | Palo Alto | Series D+ | Series D | 2026-02-03 | $252.0M |
| 23 | Heidi Health | Cremorne | Series B | Series B | 2025-10-06 | $91.6M |
| 24 | Hike Medical | San Francisco | Series A | Series A | 2026-08-25 | $27.5M |
| 25 | Ambience Healthcare | San Francisco | Series C | Series C | 2025-07-29 | $319.3M |
| 26 | Tennr | New York | Series C | Series C | 2025-06-18 | $161.0M |
| 27 | Eight Sleep | New York | Series D+ | Series D | 2026-03-04 | $301.8M |
| 28 | Remepy | Ramat Gan | Series A | Series A | 2026-08-12 | $51.0M |
| 29 | Ratio Therapeutics | Boston | Series C | Series C | 2026-07-31 | $160.0M |
| 30 | Abcuro | Newton | Series D+ | Series D | 2026-08-18 | $512.6M |
| 31 | Vestwell | New York | Series D+ | Series E | 2026-02-18 | $623.8M |
| 32 | Clairity | Austin | Series B | Series B | 2025-11-13 | $49.7M |
| 33 | Electra Therapeutics | San Francisco | Series C | Series C | 2025-10-22 | |
| 34 | Qualified Health | San Carlos | Series B | Series B | 2026-03-25 | $155.0M |
| 35 | Isaac Health | New York | Series A | Series A | 2025-08-14 | $17.5M |
| 36 | Teal Health | San Francisco | Series A | Series A | 2026-08-12 | $39.7M |
| 37 | Vaderis Therapeutics | Basel | Series B | Series B | 2026-08-11 | $170.6M |
| 38 | Cartography Biosciences | South San Francisco | Series B | Series B | 2025-10-02 | |
| 39 | Hippocratic AI | Palo Alto | Series C | Series C | 2025-11-03 | $402.0M |
| 40 | QuantHealth | Tel Aviv | Series B | Series B | 2026-08-04 | $62.0M |
| 41 | Inocras | San Diego | Series B | Series B | 2026-07-01 | $52.7M |
| 42 | Nuclera | Cambridge | Series C | Series C | 2026-01-13 | $157.8M |
| 43 | Braveheart Bio | San Francisco | Series A | Series A | 2025-11-05 | $185.0M |
| 44 | AusperBio | San Mateo | Series C | Series C | 2026-08-27 | $357.0M |
| 45 | Nourish | New York | Series B | Series B | 2025-04-23 | |
| 46 | Pearl | West Hollywood | Series B | Series B | 2024-07-24 | $69.0M |
| 47 | Kashable | New York | Series C | Series C | 2026-04-27 | $472.6M |
| 48 | Alaffia Health | New York | Series B | Series B | 2026-02-03 | $71.6M |
| 49 | Flagler Health | New York | Series B | Series B | 2026-08-11 | $58.5M |
| 50 | Trogenix | Edinburgh | Series A | Series A | 2025-10-06 | |
| 51 | Massive Bio | New York | Series B | Series B | 2022-06-02 | $23.8M |
| 52 | Eikon Therapeutics | Hayward | Series D+ | Series D | 2025-02-26 | $1.1B |
| 53 | Onos Health | San Francisco | Series A | Series A | 2026-08-26 | $23.3M |
| 54 | Leal Therapeutics | Worcester | Series A | Series A | 2026-08-17 | $144.0M |
| 55 | Qureight | Cambridge | Series B | Series B | 2026-07-29 | $31.2M |
| 56 | Varda | El Segundo | Series D+ | Series D | 2026-02-17 | $603.1M |
| 57 | Zingage | New York | Seed | Seed | 2025-10-07 | |
| 58 | Candid Health | San Francisco | Series D+ | Series D | 2026-07-22 | $219.8M |
| 59 | Grow Therapy | New York | Series D+ | Series D | 2026-03-03 | $328.0M |
| 60 | BillionToOne | Menlo Park | Series D+ | Series D | 2024-06-21 | $425.9M |
| 61 | Doctronic | New York | Series B | Series B | 2026-03-23 | $65.0M |
| 62 | LUCID | Toronto | Pre-seed | Pre-seed | 2022-08-12 | |
| 63 | Big Idea Ventures | New York | Pre-seed | Pre-seed | 2021-01-15 | |
| 64 | Medable | Palo Alto | Series D+ | Series D | 2021-10-26 | $506.6M |
| 65 | Lumen | Tel Aviv | Series B | Series B | 2022-12-01 | |
| 66 | Iambic | San Diego | Series B | Series B | 2025-11-10 | $303.0M |
| 67 | Metriport | San Francisco | Series A | Series A | 2026-08-27 | $28.4M |
| 68 | Throne | Austin | Series A | Series A | 2026-07-28 | $15.2M |
| 69 | Avenzo Therapeutics | San Diego | Series B | Series B | 2025-09-04 | $841.9M |
| 70 | Amplifica | San Diego | Series B | Series B | 2026-08-12 | $37.8M |
| 71 | SAGA Diagnostics | Morrisville | Series A | Series A | 2021-06-29 | $18.0M |
| 72 | WHOOP | Boston | Series D+ | Series G | 2026-03-31 | $979.8M |
| 73 | Metsera | New York | Series B | Series B | 2024-11-13 | |
| 74 | Alloy Therapeutics | Waltham | Series D+ | Series E | 2026-04-15 | $168.2M |
| 75 | Eleos Health | Boston | Series C | Series C | 2025-01-22 | |
| 76 | Caldera Therapeutics | Cambridge | Series A | Series A | 2026-01-14 | $112.5M |
| 77 | SuperDial | San Francisco | Series A | Series A | 2025-06-24 | |
| 78 | Brightline | Palo Alto | Series C | Series C | 2022-07-12 | $212.0M |
| 79 | AdvanCell | Sydney | Series D+ | Series D | 2026-07-15 | $452.9M |
| 80 | Avalyn Pharma | Seattle | Series D+ | Series D | 2025-07-22 | $372.5M |
| 81 | Biorce | Barcelona | Series A | Series A | 2026-02-02 | $61.5M |
| 82 | Kardigan | South San Francisco | Series B | Series B | 2025-10-14 | |
| 83 | Alma | Brooklyn | Series D+ | Series D | 2022-08-25 | $220.5M |
| 84 | CoreMap | Burlington | Series C | Series C | 2026-07-29 | $78.4M |
| 85 | Ambros Therapeutics | Irvine | Series A | Series A | 2025-12-16 | $125.0M |
| 86 | MaxQ Medical | Sunnyvale | Series A | Series A | 2026-08-20 | $31.6M |
| 87 | Nabla | Paris | Series C | Series C | 2025-06-17 | $114.6M |
| 88 | Transcarent | San Francisco | Series D+ | Series D | 2025-04-08 | $905.0M |
| 89 | Rain | Nashville | Series B | Series B | 2025-02-10 | $557.6M |
| 90 | Khartis Therapeutics | San Diego | Series B | Series B | 2026-08-13 | $95.0M |
| 91 | Cityblock Health | Brooklyn | Series D+ | Series E | 2026-08-20 | $1.0B |
| 92 | Cedar | New York | Series D+ | Series D | 2022-12-19 | $419.4M |
| 93 | Bios Life | Boston | Seed | Seed | 2026-08-10 | $25.0M |
| 94 | David | New York | Series A | Series A | 2025-05-29 | $85.0M |
| 95 | Benepass | New York | Series B | Series B | 2026-01-21 | $74.7M |
| 96 | TraceLink | North Reading | Series D+ | Series D | 2018-08-21 | $233.9M |
| 97 | Willow | Mountain View | Series D+ | Series D | 2022-09-20 | |
| 98 | Bunkerhill Health | Palo Alto | Series B | Series B | 2026-07-16 | $55.0M |
| 99 | K2 Therapeutics | Boston | Seed | Seed | 2026-08-11 | $50.0M |
| 100 | Kailera Therapeutics | Waltham | Series B | Series B | 2025-10-14 | $1.0B |
Table 1. Top health care startups, by total raised. Source: FundingWatcher. Data as of 4 September 2026. Base: 27,738.
Funding stages
Cities
Countries
Cite: FundingWatcher, 27,738 startups, 4 September 2026. https://fundingwatcher.com/startups/health-care/